EU/3/03/160

  • Email
  • Help

Orphan designation

Name Language First published Last updated
EU/3/03/160: Public summary of positive opinion for orphan designation of antisense oligonucleotide (TATCCGGAGGGCTCGCCATGCTGCT) for the treatment of retinopathy of prematurity (English only) 26/04/2004  

Key facts

Product details for <p>Antisense oligonucleotide (TATCCGGAGGGCTCGCCATGCTGCT)</p>
Active substanceAntisense oligonucleotide (TATCCGGAGGGCTCGCCATGCTGCT)
Medicine Name
Disease/conditionTreatment of retinopathy of prematurity
Date of decision02/10/2003
OutcomePositive
Orphan decision numberEU/3/03/160

Review of designation